Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

SOLY

Soliton (SOLY)

Soliton Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SOLY
DateTimeSourceHeadlineSymbolCompany
03/06/20205:10PMEdgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:SOLYSoliton Inc
03/03/20205:09PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SOLYSoliton Inc
03/03/20208:00AMPR Newswire (US)Soliton to Present Pivotal Cellulite Clinical Trial Results at AAD on March 21, 2020NASDAQ:SOLYSoliton Inc
03/02/20204:10PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SOLYSoliton Inc
03/02/20204:07PMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:SOLYSoliton Inc
03/02/20204:01PMPR Newswire (US)Soliton Reports Fourth Quarter and Full Year 2019 ResultsNASDAQ:SOLYSoliton Inc
02/12/20205:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SOLYSoliton Inc
02/12/20205:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SOLYSoliton Inc
02/12/20205:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SOLYSoliton Inc
02/12/20204:55PMEdgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:SOLYSoliton Inc
02/12/20204:53PMEdgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:SOLYSoliton Inc
02/12/20204:48PMEdgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:SOLYSoliton Inc
02/12/20204:42PMEdgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:SOLYSoliton Inc
02/11/20202:03PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SOLYSoliton Inc
02/11/20208:00AMPR Newswire (US)Soliton Files Special 510(k) with FDA for its Generation II RAP DeviceNASDAQ:SOLYSoliton Inc
02/06/20208:00AMPR Newswire (US)Soliton Advances Market Launch Preparation; Appoints James Bucher as Senior Sales ConsultantNASDAQ:SOLYSoliton Inc
01/27/20205:25PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SOLYSoliton Inc
01/27/20208:00AMPR Newswire (US)Soliton Announces Positive Data from Extended Keloid and Hypertrophic Scar TrialsNASDAQ:SOLYSoliton Inc
01/13/20208:00AMPR Newswire (US)Soliton To Announce Keloid and Hypertrophic Scar Clinical 12-Week Trial Data at Maui Derm MeetingNASDAQ:SOLYSoliton Inc
01/07/20208:00AMPR Newswire (US)Soliton Appoints Robert "Joe" Mills as Vice President of Supply ChainNASDAQ:SOLYSoliton Inc
12/18/20198:00AMPR Newswire (US)Soliton Announces Successful Completion of Safety Testing at SGS to Support FDA Filing for Second Generation DeviceNASDAQ:SOLYSoliton Inc
12/10/20198:00AMPR Newswire (US)Soliton Appoints Mary Stoll as Senior Director of Clinical DevelopmentNASDAQ:SOLYSoliton Inc
12/03/20198:00AMPR Newswire (US)Soliton Initiates Significant Step Towards CommercializationNASDAQ:SOLYSoliton Inc
11/25/20196:03AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:SOLYSoliton Inc
11/22/20194:05PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SOLYSoliton Inc
11/21/20198:00AMPR Newswire (US)Soliton and Emphysys Enter Into a 3-year Development AgreementNASDAQ:SOLYSoliton Inc
11/12/20198:00AMPR Newswire (US)Soliton Announces First Follow-up Visit Conducted in the Pivotal Cellulite Clinical TrialNASDAQ:SOLYSoliton Inc
11/08/20194:13PMEdgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:SOLYSoliton Inc
11/07/20194:30PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SOLYSoliton Inc
11/05/20199:00AMPR Newswire (US)Soliton Completes Treatment of All Patients in Pivotal Cellulite TrialNASDAQ:SOLYSoliton Inc
 Showing the most relevant articles for your search:NASDAQ:SOLY